JONATHAN BARNES: Open Payments
NPI 1376915678 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,733 in 83 payments from 22 companies in 2025. Trend: 2023 $2,363 · 2024 $2,346 · 2025 $1,733
Food & beverage: $1,674Education: $60
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $562 |
| GlaxoSmithKline, LLC. | 10 | $184 |
| GENZYME CORPORATION | 9 | $177 |
| Regeneron Healthcare Solutions, Inc. | 5 | $140 |
| Insmed, Inc. | 5 | $108 |
| Grifols USA, LLC | 4 | $79 |
| SANOFI-AVENTIS U.S. LLC | 1 | $60 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $60 |
| United Therapeutics Corporation | 3 | $54 |
| Electromed, Inc. | 5 | $49 |
Products named: DUPIXENT, FASENRA, TEZSPIRE, AIRSUPRA, NUCALA, Arikayce, Prolastin-C Liquid, Tyvaso.
Industry payments across MO — which companies pay providers there.
